{"transactions":[{"id":4629984,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":184084,"kind":"person","name":"Eckler Matthew Joseph","position":1,"cik":"0002156044","reported_name":"Eckler Matthew Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-10-05T20:14:04.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":84000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 36 equal monthly installments beginning on November 1, 2026."}],"balance_after":84000,"derivative":{"exercise_price":1.75,"expiration_date":"2036-10-01","underlying":"Common Stock","underlying_shares":84000},"source":{"system":"sec-edgar","filing":"0002156044-26-000004","document":"form4-10052026_081058.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2156044/000215604426000004/form4-10052026_081058.xml","form_type":"4"}},{"id":747460,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":36887,"kind":"person","name":"Stelzer Laurie","position":1,"cik":"0001644348","reported_name":"Stelzer Laurie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T20:32:51.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":42000,"derivative":{"exercise_price":1.19,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001644348-26-000003","document":"form4-06052026_080643.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644348/000164434826000003/form4-06052026_080643.xml","form_type":"4"}},{"id":748498,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":41069,"kind":"person","name":"LEVINE ARNOLD J","position":1,"cik":"0001124164","reported_name":"LEVINE ARNOLD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T20:30:15.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":42000,"derivative":{"exercise_price":1.19,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001124164-26-000002","document":"form4-06052026_080603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124164/000112416426000002/form4-06052026_080603.xml","form_type":"4"}},{"id":747639,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40847,"kind":"person","name":"Gallagher Carol Giltner","position":1,"cik":"0001329959","reported_name":"Gallagher Carol Giltner","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T20:25:24.000Z","date":"2026-06-04","kind":"gift","planned":false,"acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held of record by The Gallagher Revocable Trust dated May 10, 2011 for which the reporting person serves as a trustee."}],"balance_after":42000,"derivative":{"exercise_price":1.19,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001329959-26-000002","document":"form4-06052026_080616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1329959/000132995926000002/form4-06052026_080616.xml","form_type":"4"}},{"id":747638,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40847,"kind":"person","name":"Gallagher Carol Giltner","position":1,"cik":"0001329959","reported_name":"Gallagher Carol Giltner","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T20:25:24.000Z","date":"2026-06-04","kind":"gift","planned":false,"acquired":false,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":0,"derivative":{"exercise_price":1.19,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001329959-26-000002","document":"form4-06052026_080616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1329959/000132995926000002/form4-06052026_080616.xml","form_type":"4"}},{"id":747637,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40847,"kind":"person","name":"Gallagher Carol Giltner","position":1,"cik":"0001329959","reported_name":"Gallagher Carol Giltner","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T20:25:24.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":42000,"derivative":{"exercise_price":1.19,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001329959-26-000002","document":"form4-06052026_080616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329959/000132995926000002/form4-06052026_080616.xml","form_type":"4"}},{"id":748100,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T20:23:21.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":42000,"derivative":{"exercise_price":1.19,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001797209-26-000002","document":"form4-06052026_080614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000179720926000002/form4-06052026_080614.xml","form_type":"4"}},{"id":747505,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":36227,"kind":"person","name":"BAUM CHARLES M","position":1,"cik":"0001579824","reported_name":"BAUM CHARLES M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T20:20:48.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":42000,"derivative":{"exercise_price":1.19,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001579824-26-000003","document":"form4-06052026_080642.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579824/000157982426000003/form4-06052026_080642.xml","form_type":"4"}},{"id":853060,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61967,"kind":"person","name":"Jalota Deepika","position":1,"cik":"0001825192","reported_name":"Jalota Deepika","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-09T20:36:57.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":303310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on April 5, 2026."}],"balance_after":303310,"derivative":{"exercise_price":1.53,"expiration_date":"2036-03-05","underlying":"Common Stock","underlying_shares":303310},"source":{"system":"sec-edgar","filing":"0001825192-26-000002","document":"form4-03092026_080350.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000182519226000002/form4-03092026_080350.xml","form_type":"4"}},{"id":853851,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":62056,"kind":"person","name":"Carulli Michael","position":1,"cik":"0002006668","reported_name":"Carulli Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-09T16:41:27.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the option vest in 48 equal monthly installments beginning on April 5, 2026."}],"balance_after":240000,"derivative":{"exercise_price":1.53,"expiration_date":"2036-03-05","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0002006668-26-000002","document":"form4-03092026_080319.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2006668/000200666826000002/form4-03092026_080319.xml","form_type":"4"}},{"id":853087,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61970,"kind":"person","name":"Ticktin Robert","position":1,"cik":"0001613482","reported_name":"Ticktin Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-09T16:39:59.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":319270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on April 3, 2026."}],"balance_after":319270,"derivative":{"exercise_price":1.53,"expiration_date":"2035-03-05","underlying":"Common Stock","underlying_shares":319270},"source":{"system":"sec-edgar","filing":"0001613482-26-000002","document":"form4-03092026_080354.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1613482/000161348226000002/form4-03092026_080354.xml","form_type":"4"}},{"id":853228,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-09T16:35:20.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":744960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on April 5, 2026."}],"balance_after":744960,"derivative":{"exercise_price":1.53,"expiration_date":"2036-03-05","underlying":"Common Stock","underlying_shares":744960},"source":{"system":"sec-edgar","filing":"0001341642-26-000002","document":"form4-03092026_080314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000134164226000002/form4-03092026_080314.xml","form_type":"4"}},{"id":1011812,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-10-29T16:11:57.000Z","date":"2025-10-27","kind":"exercise","planned":false,"acquired":false,"shares":220643,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.37,"expiration_date":"2026-11-16","underlying":"Common Stock","underlying_shares":220643},"source":{"system":"sec-edgar","filing":"0001341642-25-000004","document":"form4-10292025_081048.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000134164225000004/form4-10292025_081048.xml","form_type":"4"}},{"id":1011811,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-10-29T16:11:57.000Z","date":"2025-10-27","kind":"exercise","planned":false,"acquired":true,"shares":220643,"price":1.37,"value":302280.91,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Excludes 305,667 shares previously reported as held directly by the reporting person which were re-registered on August 13, 2025 and are now held of record by the Mack-Mulligan Revocable Trust  (the \"Revocable Trust\")."}],"balance_after":451109,"source":{"system":"sec-edgar","filing":"0001341642-25-000004","document":"form4-10292025_081048.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000134164225000004/form4-10292025_081048.xml","form_type":"4"}},{"id":1013366,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":24290,"kind":"person","name":"ORBIMED ADVISORS LLC","position":1,"cik":"0001055951","reported_name":"ORBIMED ADVISORS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":53130,"kind":"organization","name":"OrbiMed Capital GP V LLC","position":2,"cik":"0001615374","reported_name":"OrbiMed Capital GP V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-27T21:19:23.000Z","date":"2025-10-23","kind":"sale","planned":false,"acquired":false,"shares":1000000,"price":1.52,"value":1520000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held of record by OrbiMed Private Investments V, LP (\"OPI V\"). OrbiMed Capital GP V LLC (\"GP V\") is the general partner of OPI V, and OrbiMed Advisors LLC (\"OrbiMed Advisors\"), a registered investment advisor under the Investment Advisors Act of 1940, as amended, is the managing member of GP V. By virtue of such relationships, GP V and OrbiMed Advisors may be deemed to have voting and investment power with respect to the securities held by OPI V. OrbiMed Advisors exercises this investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by OPI V."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This report on Form 4 is jointly filed by OrbiMed Advisors and GP V. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1943, as amended (the \"Exchange Act\"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any such entity is a beneficial owner of such securities for purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":4975291,"source":{"system":"sec-edgar","filing":"0000947871-25-000927","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055951/000094787125000927/ownership.xml","form_type":"4"}},{"id":1041918,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":24290,"kind":"person","name":"ORBIMED ADVISORS LLC","position":1,"cik":"0001055951","reported_name":"ORBIMED ADVISORS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":53130,"kind":"organization","name":"OrbiMed Capital GP V LLC","position":2,"cik":"0001615374","reported_name":"OrbiMed Capital GP V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T21:09:08.000Z","date":"2025-09-10","kind":"sale","planned":false,"acquired":false,"shares":500000,"price":1.8,"value":900000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held of record by OrbiMed Private Investments V, LP (\"OPI V\"). OrbiMed Capital GP V LLC (\"GP V\") is the general partner of OPI V, and OrbiMed Advisors LLC (\"OrbiMed Advisors\"), a registered investment advisor under the Investment Advisors Act of 1940, as amended, is the managing member of GP V. By virtue of such relationships, GP V and OrbiMed Advisors may be deemed to have voting and investment power with respect to the securities held by OPI V. OrbiMed Advisors exercises this investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by OPI V."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This report on Form 4 is jointly filed by OrbiMed Advisors and GP V. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1943, as amended (the \"Exchange Act\"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any such entity is a beneficial owner of such securities for purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":5975291,"source":{"system":"sec-edgar","filing":"0000947871-25-000854","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055951/000094787125000854/ownership.xml","form_type":"4"}},{"id":1091791,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61967,"kind":"person","name":"Jalota Deepika","position":1,"cik":"0001825192","reported_name":"Jalota Deepika","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-07-03T23:50:11.000Z","date":"2025-07-01","kind":"sale","planned":false,"acquired":false,"shares":33065,"price":1.0645,"value":35197.6925,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs."}],"balance_after":89959,"source":{"system":"sec-edgar","filing":"0001415889-25-019384","document":"form4-07032025_110708.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000141588925019384/form4-07032025_110708.xml","form_type":"4"}},{"id":1091826,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61970,"kind":"person","name":"Ticktin Robert","position":1,"cik":"0001613482","reported_name":"Ticktin Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & COO"}}],"security":"Common Stock","published_at":"2025-07-03T19:51:53.000Z","date":"2025-07-01","kind":"sale","planned":false,"acquired":false,"shares":23151,"price":1.0648,"value":24651.1848,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,528 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025."}],"balance_after":98695,"source":{"system":"sec-edgar","filing":"0001415889-25-019386","document":"form4-07032025_110750.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1613482/000141588925019386/form4-07032025_110750.xml","form_type":"4"}},{"id":1092807,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":62056,"kind":"person","name":"Carulli Michael","position":1,"cik":"0002006668","reported_name":"Carulli Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-03T19:49:20.000Z","date":"2025-07-01","kind":"sale","planned":false,"acquired":false,"shares":28249,"price":1.0647,"value":30076.7103,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs."}],"balance_after":60146,"source":{"system":"sec-edgar","filing":"0001415889-25-019382","document":"form4-07032025_110716.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006668/000141588925019382/form4-07032025_110716.xml","form_type":"4"}},{"id":1092020,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-03T19:48:00.000Z","date":"2025-07-01","kind":"sale","planned":false,"acquired":false,"shares":58411,"price":1.0645,"value":62178.5095,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,528 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025."}],"balance_after":536133,"source":{"system":"sec-edgar","filing":"0001415889-25-019380","document":"form4-07032025_110757.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000141588925019380/form4-07032025_110757.xml","form_type":"4"}},{"id":1117353,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":36887,"kind":"person","name":"Stelzer Laurie","position":1,"cik":"0001644348","reported_name":"Stelzer Laurie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:30:45.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 5, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":33500,"derivative":{"exercise_price":0.95,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":33500},"source":{"system":"sec-edgar","filing":"0001415889-25-016276","document":"form4-06092025_080633.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644348/000141588925016276/form4-06092025_080633.xml","form_type":"4"}},{"id":1118423,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":41069,"kind":"person","name":"LEVINE ARNOLD J","position":1,"cik":"0001124164","reported_name":"LEVINE ARNOLD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:27:52.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 5, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":33500,"derivative":{"exercise_price":0.95,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":33500},"source":{"system":"sec-edgar","filing":"0001415889-25-016269","document":"form4-06092025_080646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124164/000141588925016269/form4-06092025_080646.xml","form_type":"4"}},{"id":1117424,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":28195,"kind":"person","name":"Heyman Richard A.","position":1,"cik":"0001584759","reported_name":"Heyman Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:26:03.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 5, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":33500,"derivative":{"exercise_price":0.95,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":33500},"source":{"system":"sec-edgar","filing":"0001415889-25-016266","document":"form4-06092025_080655.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584759/000141588925016266/form4-06092025_080655.xml","form_type":"4"}},{"id":1117543,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40847,"kind":"person","name":"Gallagher Carol Giltner","position":1,"cik":"0001329959","reported_name":"Gallagher Carol Giltner","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:23:49.000Z","date":"2025-06-05","kind":"gift","planned":false,"acquired":true,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 5, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held of record by The Gallagher Revocable Trust dated May 10, 2011 for which the reporting person serves as a trustee."}],"balance_after":33500,"derivative":{"exercise_price":0.95,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":33500},"source":{"system":"sec-edgar","filing":"0001415889-25-016262","document":"form4-06092025_080644.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1329959/000141588925016262/form4-06092025_080644.xml","form_type":"4"}},{"id":1117542,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40847,"kind":"person","name":"Gallagher Carol Giltner","position":1,"cik":"0001329959","reported_name":"Gallagher Carol Giltner","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:23:49.000Z","date":"2025-06-05","kind":"gift","planned":false,"acquired":false,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 5, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":0,"derivative":{"exercise_price":0.95,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":33500},"source":{"system":"sec-edgar","filing":"0001415889-25-016262","document":"form4-06092025_080644.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1329959/000141588925016262/form4-06092025_080644.xml","form_type":"4"}},{"id":1117541,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40847,"kind":"person","name":"Gallagher Carol Giltner","position":1,"cik":"0001329959","reported_name":"Gallagher Carol Giltner","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:23:49.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 5, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":33500,"derivative":{"exercise_price":0.95,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":33500},"source":{"system":"sec-edgar","filing":"0001415889-25-016262","document":"form4-06092025_080644.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329959/000141588925016262/form4-06092025_080644.xml","form_type":"4"}},{"id":1118015,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:22:20.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 5, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":33500,"derivative":{"exercise_price":0.95,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":33500},"source":{"system":"sec-edgar","filing":"0001415889-25-016259","document":"form4-06092025_080616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000141588925016259/form4-06092025_080616.xml","form_type":"4"}},{"id":1117429,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":36227,"kind":"person","name":"BAUM CHARLES M","position":1,"cik":"0001579824","reported_name":"BAUM CHARLES M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:20:35.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 5, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":33500,"derivative":{"exercise_price":0.95,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":33500},"source":{"system":"sec-edgar","filing":"0001415889-25-016254","document":"form4-06092025_080615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579824/000141588925016254/form4-06092025_080615.xml","form_type":"4"}},{"id":1221474,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61967,"kind":"person","name":"Jalota Deepika","position":1,"cik":"0001825192","reported_name":"Jalota Deepika","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-05T23:32:27.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the option vest in 48 equal monthly installments beginning on April 3, 2025."}],"balance_after":300000,"derivative":{"exercise_price":1.32,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001415889-25-007073","document":"form4-03052025_110323.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000141588925007073/form4-03052025_110323.xml","form_type":"4"}},{"id":1223132,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":62056,"kind":"person","name":"Carulli Michael","position":1,"cik":"0002006668","reported_name":"Carulli Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-05T18:34:12.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":265000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on April 3, 2025."}],"balance_after":265000,"derivative":{"exercise_price":1.32,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":265000},"source":{"system":"sec-edgar","filing":"0001415889-25-007075","document":"form4-03052025_110309.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006668/000141588925007075/form4-03052025_110309.xml","form_type":"4"}},{"id":1221895,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-05T18:30:50.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares subject to the option vest in 48 equal monthly installments beginning on April 3, 2025."}],"balance_after":800000,"derivative":{"exercise_price":1.32,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001415889-25-007071","document":"form4-03052025_110346.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000141588925007071/form4-03052025_110346.xml","form_type":"4"}},{"id":1297333,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-22T16:37:33.000Z","date":"2025-01-03","kind":"exercise","planned":false,"acquired":false,"shares":17709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.53,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":17709},"source":{"system":"sec-edgar","filing":"0001415889-25-001853","document":"form4-01222025_090129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000141588925001853/form4-01222025_090129.xml","form_type":"4"}},{"id":1297332,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-22T16:37:33.000Z","date":"2024-12-03","kind":"exercise","planned":false,"acquired":false,"shares":91750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":17709,"derivative":{"exercise_price":0.53,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":91750},"source":{"system":"sec-edgar","filing":"0001415889-25-001853","document":"form4-01222025_090129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000141588925001853/form4-01222025_090129.xml","form_type":"4"}},{"id":1297331,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-22T16:37:33.000Z","date":"2025-01-03","kind":"exercise","planned":false,"acquired":true,"shares":17709,"price":0.53,"value":9385.77,"ownership":{"direct":true},"balance_after":551919,"source":{"system":"sec-edgar","filing":"0001415889-25-001853","document":"form4-01222025_090129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000141588925001853/form4-01222025_090129.xml","form_type":"4"}},{"id":1297330,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-22T16:37:33.000Z","date":"2024-12-03","kind":"exercise","planned":false,"acquired":true,"shares":91750,"price":0.53,"value":48627.5,"ownership":{"direct":true},"balance_after":534210,"source":{"system":"sec-edgar","filing":"0001415889-25-001853","document":"form4-01222025_090129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000141588925001853/form4-01222025_090129.xml","form_type":"4"}},{"id":1391391,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61967,"kind":"person","name":"Jalota Deepika","position":1,"cik":"0001825192","reported_name":"Jalota Deepika","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-03T20:50:25.000Z","date":"2024-08-13","kind":"grant","planned":false,"acquired":true,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 125,000 shares of PMV common stock granted to the reporting person on May 12, 2023. In exchange, the reporting person received a replacement option, for 125,000 shares, having an exercise price of $1.48 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"One-fourth of the shares subject to the option vest on August 13, 2025 and 1/48th vest monthly thereafter."}],"balance_after":125000,"derivative":{"exercise_price":1.49,"expiration_date":"2034-03-13","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-24-024627","document":"form4-10032024_081022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000141588924024627/form4-10032024_081022.xml","form_type":"4"}},{"id":1391390,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61967,"kind":"person","name":"Jalota Deepika","position":1,"cik":"0001825192","reported_name":"Jalota Deepika","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-03T20:50:25.000Z","date":"2024-08-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 125,000 shares of PMV common stock granted to the reporting person on May 12, 2023. In exchange, the reporting person received a replacement option, for 125,000 shares, having an exercise price of $1.48 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2023."}],"balance_after":0,"derivative":{"exercise_price":5.7,"expiration_date":"2033-05-12","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-24-024627","document":"form4-10032024_081022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000141588924024627/form4-10032024_081022.xml","form_type":"4"}},{"id":1391389,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61967,"kind":"person","name":"Jalota Deepika","position":1,"cik":"0001825192","reported_name":"Jalota Deepika","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-03T20:50:25.000Z","date":"2024-08-13","kind":"grant","planned":false,"acquired":true,"shares":90774,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 22,674 shares of PMV common stock granted to the reporting person on May 12, 2021. In exchange, the reporting person received a replacement option, for 22,674 shares, having an exercise price of $1.48 per share."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 68,100 shares of PMV common stock granted to the reporting person on February 10, 2022. In exchange, the reporting person received a replacement option, for 68,100 shares, having an exercise price of $1.48 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-third of the shares subject to the option vest on August 13, 2025 and 1/36th vest monthly thereafter."}],"balance_after":90774,"derivative":{"exercise_price":1.48,"expiration_date":"2034-08-13","underlying":"Common Stock","underlying_shares":90774},"source":{"system":"sec-edgar","filing":"0001415889-24-024627","document":"form4-10032024_081022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000141588924024627/form4-10032024_081022.xml","form_type":"4"}},{"id":1391388,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61967,"kind":"person","name":"Jalota Deepika","position":1,"cik":"0001825192","reported_name":"Jalota Deepika","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-03T20:50:25.000Z","date":"2024-08-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":68100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 68,100 shares of PMV common stock granted to the reporting person on February 10, 2022. In exchange, the reporting person received a replacement option, for 68,100 shares, having an exercise price of $1.48 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the option vest in 48 equal monthly installments beginning on March 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":16.29,"expiration_date":"2033-02-10","underlying":"Common Stock","underlying_shares":68100},"source":{"system":"sec-edgar","filing":"0001415889-24-024627","document":"form4-10032024_081022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000141588924024627/form4-10032024_081022.xml","form_type":"4"}},{"id":1391387,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61967,"kind":"person","name":"Jalota Deepika","position":1,"cik":"0001825192","reported_name":"Jalota Deepika","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-03T20:50:25.000Z","date":"2024-08-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22674,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 22,674 shares of PMV common stock granted to the reporting person on May 12, 2021. In exchange, the reporting person received a replacement option, for 22,674 shares, having an exercise price of $1.48 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2021."}],"balance_after":0,"derivative":{"exercise_price":28.33,"expiration_date":"2031-05-11","underlying":"Common Stock","underlying_shares":22674},"source":{"system":"sec-edgar","filing":"0001415889-24-024627","document":"form4-10032024_081022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000141588924024627/form4-10032024_081022.xml","form_type":"4"}},{"id":1392387,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":62056,"kind":"person","name":"Carulli Michael","position":1,"cik":"0002006668","reported_name":"Carulli Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-03T16:48:44.000Z","date":"2024-08-13","kind":"grant","planned":false,"acquired":true,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 75,000 shares of PMV common stock granted to the reporting person on May 12, 2023. In exchange, the reporting person received a replacement option, for 75,000 shares, having an exercise price of $1.48 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"One-fourth of the shares subject to the option vest on August 13, 2025 and 1/48th vest monthly thereafter."}],"balance_after":75000,"derivative":{"exercise_price":1.48,"expiration_date":"2034-08-13","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-24-024624","document":"form4-10032024_081040.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2006668/000141588924024624/form4-10032024_081040.xml","form_type":"4"}},{"id":1392386,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":62056,"kind":"person","name":"Carulli Michael","position":1,"cik":"0002006668","reported_name":"Carulli Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-03T16:48:44.000Z","date":"2024-08-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 75,000 shares of PMV common stock granted to the reporting person on May 12, 2023. In exchange, the reporting person received a replacement option, for 75,000 shares, having an exercise price of $1.48 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Shares subject to the option vest in 48 equal monthly installments beginning on June 12. 2023."}],"balance_after":75000,"derivative":{"exercise_price":5.7,"expiration_date":"2033-05-12","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-24-024624","document":"form4-10032024_081040.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2006668/000141588924024624/form4-10032024_081040.xml","form_type":"4"}},{"id":1392385,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":62056,"kind":"person","name":"Carulli Michael","position":1,"cik":"0002006668","reported_name":"Carulli Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-03T16:48:44.000Z","date":"2024-08-13","kind":"grant","planned":false,"acquired":true,"shares":40805,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 13,605 shares of PMV common stock granted to the reporting person on May 12, 2021. In exchange, the reporting person received a replacement option, for 13,605 shares, having an exercise price of $1.48 per share."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 27,200 shares of PMV common stock granted to the reporting person on February 10, 2022. In exchange, the reporting person received a replacement option, for 27,200 shares, having an exercise price of $1.48 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-third of the shares subject to the option vest on August 13, 2025 and 1/36th vest monthly thereafter."}],"balance_after":40805,"derivative":{"exercise_price":1.48,"expiration_date":"2034-08-13","underlying":"Common Stock","underlying_shares":40805},"source":{"system":"sec-edgar","filing":"0001415889-24-024624","document":"form4-10032024_081040.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2006668/000141588924024624/form4-10032024_081040.xml","form_type":"4"}},{"id":1392384,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":62056,"kind":"person","name":"Carulli Michael","position":1,"cik":"0002006668","reported_name":"Carulli Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-03T16:48:44.000Z","date":"2024-08-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":27200,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 27,200 shares of PMV common stock granted to the reporting person on February 10, 2022. In exchange, the reporting person received a replacement option, for 27,200 shares, having an exercise price of $1.48 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the option vest in 48 equal monthly installments beginning on March 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":16.29,"expiration_date":"2032-02-10","underlying":"Common Stock","underlying_shares":27200},"source":{"system":"sec-edgar","filing":"0001415889-24-024624","document":"form4-10032024_081040.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2006668/000141588924024624/form4-10032024_081040.xml","form_type":"4"}},{"id":1392383,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":62056,"kind":"person","name":"Carulli Michael","position":1,"cik":"0002006668","reported_name":"Carulli Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-03T16:48:44.000Z","date":"2024-08-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13605,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 13,605 shares of PMV common stock granted to the reporting person on May 12, 2021. In exchange, the reporting person received a replacement option, for 13,605 shares, having an exercise price of $1.48 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2021."}],"balance_after":0,"derivative":{"exercise_price":28.33,"expiration_date":"2031-05-12","underlying":"Common Stock","underlying_shares":13605},"source":{"system":"sec-edgar","filing":"0001415889-24-024624","document":"form4-10032024_081040.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006668/000141588924024624/form4-10032024_081040.xml","form_type":"4"}},{"id":1391636,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-03T16:44:08.000Z","date":"2024-08-13","kind":"grant","planned":false,"acquired":true,"shares":330000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 330,000 shares of PMV common stock granted to the reporting person on May 12, 2023. In exchange, the reporting person received a replacement option, for 330,000 shares, having an exercise price of $1.48 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"One-fourth of the shares subject to the option vest on August 13, 2025 and 1/48th vest monthly thereafter."}],"balance_after":330000,"derivative":{"exercise_price":1.48,"expiration_date":"2034-08-13","underlying":"Common Stock","underlying_shares":330000},"source":{"system":"sec-edgar","filing":"0001415889-24-024622","document":"form4-10032024_081002.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000141588924024622/form4-10032024_081002.xml","form_type":"4"}},{"id":1391635,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-03T16:44:08.000Z","date":"2024-08-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":330000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 330,000 shares of PMV common stock granted to the reporting person on May 12, 2023. In exchange, the reporting person received a replacement option, for 330,000 shares, having an exercise price of $1.48 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2023."}],"balance_after":0,"derivative":{"exercise_price":5.7,"expiration_date":"2033-05-12","underlying":"Common Stock","underlying_shares":330000},"source":{"system":"sec-edgar","filing":"0001415889-24-024622","document":"form4-10032024_081002.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000141588924024622/form4-10032024_081002.xml","form_type":"4"}},{"id":1391634,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-03T16:44:08.000Z","date":"2024-08-13","kind":"grant","planned":false,"acquired":true,"shares":384184,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 134,584 shares of PMV common stock granted to the reporting person on May 12, 2021. In exchange, the reporting person received a replacement option, for 134,584 shares, having an exercise price of $1.48 per share."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 249,600 shares of PMV common stock granted to the reporting person on February 10, 2022. In exchange, the reporting person received a replacement option, for 249,600 shares, having an exercise price of $1.48 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-third of the shares subject to the option vest on August 13, 2025 and 1/36th vest monthly thereafter."}],"balance_after":384184,"derivative":{"exercise_price":1.48,"expiration_date":"2034-08-13","underlying":"Common Stock","underlying_shares":384184},"source":{"system":"sec-edgar","filing":"0001415889-24-024622","document":"form4-10032024_081002.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000141588924024622/form4-10032024_081002.xml","form_type":"4"}},{"id":1391633,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-03T16:44:08.000Z","date":"2024-08-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":249600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 249,600 shares of PMV common stock granted to the reporting person on February 10, 2022. In exchange, the reporting person received a replacement option, for 249,600 shares, having an exercise price of $1.48 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the option vest in 48 equal monthly installments beginning on March 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":16.29,"expiration_date":"2032-02-10","underlying":"Common Stock","underlying_shares":249600},"source":{"system":"sec-edgar","filing":"0001415889-24-024622","document":"form4-10032024_081002.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000141588924024622/form4-10032024_081002.xml","form_type":"4"}},{"id":1391632,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-03T16:44:08.000Z","date":"2024-08-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":134584,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 134,584 shares of PMV common stock granted to the reporting person on May 12, 2021. In exchange, the reporting person received a replacement option, for 134,584 shares, having an exercise price of $1.48 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2021."}],"balance_after":0,"derivative":{"exercise_price":28.33,"expiration_date":"2031-05-11","underlying":"Common Stock","underlying_shares":134584},"source":{"system":"sec-edgar","filing":"0001415889-24-024622","document":"form4-10032024_081002.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000141588924024622/form4-10032024_081002.xml","form_type":"4"}},{"id":1408329,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61967,"kind":"person","name":"Jalota Deepika","position":1,"cik":"0001825192","reported_name":"Jalota Deepika","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-09-12T22:00:51.000Z","date":"2024-09-11","kind":"sale","planned":false,"acquired":false,"shares":7218,"price":1.5036,"value":10852.9848,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to cover the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs."}],"balance_after":118283,"source":{"system":"sec-edgar","filing":"0001415889-24-023313","document":"form4-09122024_100948.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000141588924023313/form4-09122024_100948.xml","form_type":"4"}},{"id":1408857,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":62056,"kind":"person","name":"Carulli Michael","position":1,"cik":"0002006668","reported_name":"Carulli Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-12T17:59:12.000Z","date":"2024-09-11","kind":"sale","planned":false,"acquired":false,"shares":2891,"price":1.5036,"value":4346.9076,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These reported shares were sold to cover the reporting person's tax obligation in connection with the vesting of restricted stock units, or RSUs."}],"balance_after":88395,"source":{"system":"sec-edgar","filing":"0001415889-24-023309","document":"form4-09122024_090908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006668/000141588924023309/form4-09122024_090908.xml","form_type":"4"}},{"id":1484433,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":36887,"kind":"person","name":"Stelzer Laurie","position":1,"cik":"0001644348","reported_name":"Stelzer Laurie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-10T20:44:40.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: 22,500 shares vest on the earlier of (i) June 6, 2025 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders and the remaining 45,000 shares vest in 36 equal monthly installments beginning on July 6, 2024."}],"balance_after":67500,"derivative":{"exercise_price":1.65,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0001415889-24-016238","document":"form4-06102024_080637.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644348/000141588924016238/form4-06102024_080637.xml","form_type":"4"}},{"id":1485347,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":41069,"kind":"person","name":"LEVINE ARNOLD J","position":1,"cik":"0001124164","reported_name":"LEVINE ARNOLD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-10T20:43:24.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: 22,500 shares vest on the earlier of (i) June 6, 2025 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders and the remaining 45,000 shares vest in 36 equal monthly installments beginning on July 6, 2024."}],"balance_after":67500,"derivative":{"exercise_price":1.65,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0001415889-24-016236","document":"form4-06102024_080620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124164/000141588924016236/form4-06102024_080620.xml","form_type":"4"}},{"id":1484478,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":28195,"kind":"person","name":"Heyman Richard A.","position":1,"cik":"0001584759","reported_name":"Heyman Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-10T20:22:51.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: 22,500 shares vest on the earlier of (i) June 6, 2025 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders and the remaining 45,000 shares vest in 36 equal monthly installments beginning on July 6, 2024."}],"balance_after":67500,"derivative":{"exercise_price":1.65,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0001415889-24-016214","document":"form4-06102024_080647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584759/000141588924016214/form4-06102024_080647.xml","form_type":"4"}},{"id":1484607,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40847,"kind":"person","name":"Gallagher Carol Giltner","position":1,"cik":"0001329959","reported_name":"Gallagher Carol Giltner","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-10T20:21:10.000Z","date":"2024-06-07","kind":"gift","planned":false,"acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: 22,500 shares vest on the earlier of (i) June 6, 2025 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders and the remaining 45,000 shares vest in 36 equal monthly installments beginning on July 6, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held of record by The Gallagher Revocable Trust dated May 10, 2011 for which the reporting person serves as a trustee."}],"balance_after":67500,"derivative":{"exercise_price":1.65,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0001415889-24-016208","document":"form4-06102024_080606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1329959/000141588924016208/form4-06102024_080606.xml","form_type":"4"}},{"id":1484606,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40847,"kind":"person","name":"Gallagher Carol Giltner","position":1,"cik":"0001329959","reported_name":"Gallagher Carol Giltner","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-10T20:21:10.000Z","date":"2024-06-07","kind":"gift","planned":false,"acquired":false,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: 22,500 shares vest on the earlier of (i) June 6, 2025 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders and the remaining 45,000 shares vest in 36 equal monthly installments beginning on July 6, 2024."}],"balance_after":0,"derivative":{"exercise_price":1.65,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0001415889-24-016208","document":"form4-06102024_080606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1329959/000141588924016208/form4-06102024_080606.xml","form_type":"4"}},{"id":1484605,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40847,"kind":"person","name":"Gallagher Carol Giltner","position":1,"cik":"0001329959","reported_name":"Gallagher Carol Giltner","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-10T20:21:10.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: 22,500 shares vest on the earlier of (i) June 6, 2025 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders and the remaining 45,000 shares vest in 36 equal monthly installments beginning on July 6, 2024."}],"balance_after":67500,"derivative":{"exercise_price":1.65,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0001415889-24-016208","document":"form4-06102024_080606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329959/000141588924016208/form4-06102024_080606.xml","form_type":"4"}},{"id":1485047,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-10T20:17:57.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: 22,500 shares vest on the earlier of (i) June 6, 2025 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders and the remaining 45,000 shares vest in 36 equal monthly installments beginning on July 6, 2024."}],"balance_after":67500,"derivative":{"exercise_price":1.65,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0001415889-24-016202","document":"form4-06102024_080652.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000141588924016202/form4-06102024_080652.xml","form_type":"4"}},{"id":1484495,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":36227,"kind":"person","name":"BAUM CHARLES M","position":1,"cik":"0001579824","reported_name":"BAUM CHARLES M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-10T20:15:37.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: 22,500 shares vest on the earlier of (i) June 6, 2025 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders and the remaining 45,000 shares vest in 36 equal monthly installments beginning on July 6, 2024."}],"balance_after":67500,"derivative":{"exercise_price":1.65,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0001415889-24-016199","document":"form4-06102024_080633.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579824/000141588924016199/form4-06102024_080633.xml","form_type":"4"}},{"id":1673908,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61967,"kind":"person","name":"Jalota Deepika","position":1,"cik":"0001825192","reported_name":"Jalota Deepika","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-22T21:06:16.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":225095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the option vest in 48 equal monthly installments beginning on February 18, 2024."}],"balance_after":225095,"derivative":{"exercise_price":1.8,"expiration_date":"2034-01-18","underlying":"Common Stock","underlying_shares":225095},"source":{"system":"sec-edgar","filing":"0001209191-24-001999","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919124001999/doc4.xml","form_type":"4"}},{"id":1673907,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61967,"kind":"person","name":"Jalota Deepika","position":1,"cik":"0001825192","reported_name":"Jalota Deepika","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-01-22T21:06:16.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":95555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 30, 2025."}],"balance_after":125501,"source":{"system":"sec-edgar","filing":"0001209191-24-001999","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919124001999/doc4.xml","form_type":"4"}},{"id":1674371,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":62056,"kind":"person","name":"Carulli Michael","position":1,"cik":"0002006668","reported_name":"Carulli Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-22T16:04:03.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":204630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the option vest in 48 equal monthly installments beginning on February 18, 2024."}],"balance_after":204630,"derivative":{"exercise_price":1.8,"expiration_date":"2034-01-18","underlying":"Common Stock","underlying_shares":204630},"source":{"system":"sec-edgar","filing":"0001209191-24-001995","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2006668/000120919124001995/doc4.xml","form_type":"4"}},{"id":1674370,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":62056,"kind":"person","name":"Carulli Michael","position":1,"cik":"0002006668","reported_name":"Carulli Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-22T16:04:03.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":82220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 30, 2025."}],"balance_after":91286,"source":{"system":"sec-edgar","filing":"0001209191-24-001995","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006668/000120919124001995/doc4.xml","form_type":"4"}},{"id":1674051,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-22T16:02:42.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":519915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares subject to the option vest in 48 equal monthly installments beginning on February 18, 2024."}],"balance_after":519915,"derivative":{"exercise_price":1.8,"expiration_date":"2034-01-18","underlying":"Common Stock","underlying_shares":519915},"source":{"system":"sec-edgar","filing":"0001209191-24-001993","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919124001993/doc4.xml","form_type":"4"}},{"id":1674050,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-22T16:02:42.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":163890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 30, 2025."}],"balance_after":442460,"source":{"system":"sec-edgar","filing":"0001209191-24-001993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919124001993/doc4.xml","form_type":"4"}},{"id":1730498,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":24290,"kind":"person","name":"ORBIMED ADVISORS LLC","position":1,"cik":"0001055951","reported_name":"ORBIMED ADVISORS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":53130,"kind":"organization","name":"OrbiMed Capital GP V LLC","position":2,"cik":"0001615374","reported_name":"OrbiMed Capital GP V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24740,"kind":"person","name":"OrbiMed Genesis GP LLC","position":3,"cik":"0001808744","reported_name":"OrbiMed Genesis GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-24T21:38:04.000Z","date":"2023-11-22","kind":"sale","planned":false,"acquired":false,"shares":87786,"price":2.23,"value":195762.78,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held of record by OrbiMed Genesis Master Fund, L.P. (\"Genesis Master Fund\"). OrbiMed Genesis GP LLC (\"Genesis GP\") is the general partner of Genesis Master Fund and OrbiMed Advisors LLC (\"OrbiMed Advisors\"), a registered investment advisor under the Investment Advisors Act of 1940, as amended, is the managing member of Genesis GP. By virtue of such relationships, Genesis GP and OrbiMed Advisors may be deemed to have voting and investment power with respect to the securities held by Genesis Master Fund. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by Genesis Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This report on Form 4 is jointly filed by OrbiMed Advisors, GP V and Genesis GP. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1943, as amended (the \"Exchange Act\"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any such entity is a beneficial owner of such securities for purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000947871-23-001104","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055951/000094787123001104/ownership.xml","form_type":"4"}},{"id":1743501,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-11-13T16:21:30.000Z","date":"2023-08-07","kind":"exercise","planned":false,"acquired":false,"shares":198407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":109459,"derivative":{"exercise_price":0.53,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":198407},"source":{"system":"sec-edgar","filing":"0001209191-23-054997","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919123054997/doc4.xml","form_type":"4"}},{"id":1743500,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-11-13T16:21:30.000Z","date":"2023-11-10","kind":"gift","planned":false,"acquired":true,"shares":85307,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein."}],"balance_after":165307,"source":{"system":"sec-edgar","filing":"0001209191-23-054997","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919123054997/doc4.xml","form_type":"4"}},{"id":1743499,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-11-13T16:21:30.000Z","date":"2023-11-10","kind":"gift","planned":false,"acquired":false,"shares":85307,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":278570,"source":{"system":"sec-edgar","filing":"0001209191-23-054997","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919123054997/doc4.xml","form_type":"4"}},{"id":1743498,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-11-13T16:21:30.000Z","date":"2023-10-18","kind":"exercise","planned":false,"acquired":true,"shares":198407,"price":0.53,"value":105155.71,"ownership":{"direct":true},"balance_after":363877,"source":{"system":"sec-edgar","filing":"0001209191-23-054997","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919123054997/doc4.xml","form_type":"4"}},{"id":1778616,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61967,"kind":"person","name":"Jalota Deepika","position":1,"cik":"0001825192","reported_name":"Jalota Deepika","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2023-09-18T20:26:37.000Z","date":"2023-09-15","kind":"sale","planned":false,"acquired":false,"shares":4104,"price":6.62,"value":27168.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to cover the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs."}],"balance_after":29946,"source":{"system":"sec-edgar","filing":"0001209191-23-049759","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919123049759/doc4.xml","form_type":"4"}},{"id":1778615,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-09-18T20:22:58.000Z","date":"2023-09-15","kind":"sale","planned":false,"acquired":false,"shares":6291,"price":6.62,"value":41646.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs."}],"balance_after":45909,"source":{"system":"sec-edgar","filing":"0001209191-23-049751","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919123049751/doc4.xml","form_type":"4"}},{"id":1812775,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-08-08T16:43:13.000Z","date":"2023-08-07","kind":"exercise","planned":false,"acquired":false,"shares":85500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":307866,"derivative":{"exercise_price":0.53,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":85500},"source":{"system":"sec-edgar","filing":"0001209191-23-045010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919123045010/doc4.xml","form_type":"4"}},{"id":1812774,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-08T16:43:13.000Z","date":"2023-08-07","kind":"exercise","planned":false,"acquired":true,"shares":85500,"price":0.53,"value":45315.0,"ownership":{"direct":true},"balance_after":165470,"source":{"system":"sec-edgar","filing":"0001209191-23-045010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919123045010/doc4.xml","form_type":"4"}},{"id":1858249,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":36887,"kind":"person","name":"Stelzer Laurie","position":1,"cik":"0001644348","reported_name":"Stelzer Laurie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-12T21:55:15.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 8, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":21500,"derivative":{"exercise_price":5.59,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001209191-23-036456","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644348/000120919123036456/doc4.xml","form_type":"4"}},{"id":1859259,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":41069,"kind":"person","name":"LEVINE ARNOLD J","position":1,"cik":"0001124164","reported_name":"LEVINE ARNOLD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-12T21:49:19.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 8, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":21500,"derivative":{"exercise_price":5.59,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001209191-23-036449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124164/000120919123036449/doc4.xml","form_type":"4"}},{"id":1858349,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":28195,"kind":"person","name":"Heyman Richard A.","position":1,"cik":"0001584759","reported_name":"Heyman Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-12T21:39:29.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 8, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":21500,"derivative":{"exercise_price":5.59,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001209191-23-036427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584759/000120919123036427/doc4.xml","form_type":"4"}},{"id":1858495,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40847,"kind":"person","name":"Gallagher Carol Giltner","position":1,"cik":"0001329959","reported_name":"Gallagher Carol Giltner","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-12T21:19:42.000Z","date":"2023-06-08","kind":"gift","planned":false,"acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 8, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held of record by The Gallagher Revocable Trust dated May 10, 2011 for which the reporting person serves as a trustee."}],"balance_after":21500,"derivative":{"exercise_price":5.59,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001209191-23-036383","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1329959/000120919123036383/doc4.xml","form_type":"4"}},{"id":1858494,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40847,"kind":"person","name":"Gallagher Carol Giltner","position":1,"cik":"0001329959","reported_name":"Gallagher Carol Giltner","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-12T21:19:42.000Z","date":"2023-06-08","kind":"gift","planned":false,"acquired":false,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 8, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":0,"derivative":{"exercise_price":5.59,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001209191-23-036383","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1329959/000120919123036383/doc4.xml","form_type":"4"}},{"id":1858493,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40847,"kind":"person","name":"Gallagher Carol Giltner","position":1,"cik":"0001329959","reported_name":"Gallagher Carol Giltner","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-12T21:19:42.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 8, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":21500,"derivative":{"exercise_price":5.59,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001209191-23-036383","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329959/000120919123036383/doc4.xml","form_type":"4"}},{"id":1858912,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-12T21:13:33.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 8, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":21500,"derivative":{"exercise_price":5.59,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001209191-23-036373","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000120919123036373/doc4.xml","form_type":"4"}},{"id":1858361,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":36227,"kind":"person","name":"BAUM CHARLES M","position":1,"cik":"0001579824","reported_name":"BAUM CHARLES M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-12T21:10:47.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 8, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":21500,"derivative":{"exercise_price":5.59,"expiration_date":"2023-06-08","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001209191-23-036368","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579824/000120919123036368/doc4.xml","form_type":"4"}},{"id":1893006,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61967,"kind":"person","name":"Jalota Deepika","position":1,"cik":"0001825192","reported_name":"Jalota Deepika","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-05-15T22:18:31.000Z","date":"2023-05-12","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2023."}],"balance_after":125000,"derivative":{"exercise_price":5.7,"expiration_date":"2033-05-12","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-23-029612","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919123029612/doc4.xml","form_type":"4"}},{"id":1893005,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-05-15T22:14:08.000Z","date":"2023-05-12","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2023."}],"balance_after":100000,"derivative":{"exercise_price":5.7,"expiration_date":"2033-05-12","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-23-029609","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919123029609/doc4.xml","form_type":"4"}},{"id":1893514,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-05-15T17:56:13.000Z","date":"2023-05-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2023."}],"balance_after":150000,"derivative":{"exercise_price":5.7,"expiration_date":"2033-05-12","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-23-029594","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919123029594/doc4.xml","form_type":"4"}},{"id":1893185,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-05-15T17:48:03.000Z","date":"2023-05-12","kind":"grant","planned":false,"acquired":true,"shares":330000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2023."}],"balance_after":330000,"derivative":{"exercise_price":5.7,"expiration_date":"2033-05-12","underlying":"Common Stock","underlying_shares":330000},"source":{"system":"sec-edgar","filing":"0001209191-23-029586","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919123029586/doc4.xml","form_type":"4"}},{"id":2042177,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":38792,"kind":"person","name":"Kung Winston","position":1,"cik":"0001666963","reported_name":"Kung Winston","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, CFO"}}],"security":"Common Stock","published_at":"2023-01-30T16:22:18.000Z","date":"2022-11-25","kind":"gift","acquired":false,"shares":2560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were acquired under the Issuer's stock purchase plan on November 20, 2022."}],"balance_after":10600,"source":{"system":"sec-edgar","filing":"0001209191-23-005476","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1666963/000120919123005476/doc4.xml","form_type":"4"}},{"id":2122092,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40847,"kind":"person","name":"Gallagher Carol Giltner","position":1,"cik":"0001329959","reported_name":"Gallagher Carol Giltner","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-08T21:22:36.000Z","date":"2022-11-05","kind":"gift","acquired":true,"shares":39000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option  vest in 36 equal, monthly installments beginning on December 4, 2022."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held of record by The Gallagher Revocable Trust dated May 10, 2011 for which the reporting person serves as a trustee."}],"balance_after":39000,"derivative":{"exercise_price":11.28,"expiration_date":"2032-11-03","underlying":"Common Stock","underlying_shares":39000},"source":{"system":"sec-edgar","filing":"0001209191-22-056102","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1329959/000120919122056102/doc4.xml","form_type":"4"}},{"id":2122091,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40847,"kind":"person","name":"Gallagher Carol Giltner","position":1,"cik":"0001329959","reported_name":"Gallagher Carol Giltner","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-08T21:22:36.000Z","date":"2022-11-05","kind":"gift","acquired":false,"shares":39000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option  vest in 36 equal, monthly installments beginning on December 4, 2022."}],"balance_after":39000,"derivative":{"exercise_price":11.28,"expiration_date":"2032-11-03","underlying":"Common Stock","underlying_shares":39000},"source":{"system":"sec-edgar","filing":"0001209191-22-056102","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1329959/000120919122056102/doc4.xml","form_type":"4"}},{"id":2122090,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40847,"kind":"person","name":"Gallagher Carol Giltner","position":1,"cik":"0001329959","reported_name":"Gallagher Carol Giltner","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-08T21:22:36.000Z","date":"2022-11-04","kind":"grant","acquired":true,"shares":39000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option  vest in 36 equal, monthly installments beginning on December 4, 2022."}],"balance_after":39000,"derivative":{"exercise_price":11.28,"expiration_date":"2032-11-03","underlying":"Common Stock","underlying_shares":39000},"source":{"system":"sec-edgar","filing":"0001209191-22-056102","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1329959/000120919122056102/doc4.xml","form_type":"4"}},{"id":2159866,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61967,"kind":"person","name":"Jalota Deepika","position":1,"cik":"0001825192","reported_name":"Jalota Deepika","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Regulatory Affairs and QA"}}],"security":"Common Stock","published_at":"2022-09-13T20:26:54.000Z","date":"2022-09-09","kind":"grant","acquired":true,"shares":34050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUS. One- third of the RSUs vest on September 9, 2023 and the remaining shares vest on September 9, 2024."}],"balance_after":34050,"source":{"system":"sec-edgar","filing":"0001209191-22-049694","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919122049694/doc4.xml","form_type":"4"}},{"id":2159865,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":33476,"kind":"person","name":"Alland Leila","position":1,"cik":"0001825216","reported_name":"Alland Leila","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-09-13T20:23:15.000Z","date":"2022-09-09","kind":"grant","acquired":true,"shares":52200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUS. One- third of the RSUs vest on September 9, 2023 and the remaining shares vest on September 9, 2024."}],"balance_after":52200,"source":{"system":"sec-edgar","filing":"0001209191-22-049692","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699382/000120919122049692/doc4.xml","form_type":"4"}},{"id":2241234,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":36887,"kind":"person","name":"Stelzer Laurie","position":1,"cik":"0001644348","reported_name":"Stelzer Laurie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-06-06T21:59:15.000Z","date":"2022-06-02","kind":"grant","acquired":false,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 2, 2023 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":19500,"derivative":{"exercise_price":13.56,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001209191-22-034634","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644348/000120919122034634/doc4.xml","form_type":"4"}},{"id":2242762,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":41069,"kind":"person","name":"LEVINE ARNOLD J","position":1,"cik":"0001124164","reported_name":"LEVINE ARNOLD J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-06-06T21:45:05.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 2, 2023 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":19500,"derivative":{"exercise_price":13.56,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001209191-22-034622","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124164/000120919122034622/doc4.xml","form_type":"4"}},{"id":2241258,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":28195,"kind":"person","name":"Heyman Richard A.","position":1,"cik":"0001584759","reported_name":"Heyman Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-06T21:41:49.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 2, 2023 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":19500,"derivative":{"exercise_price":13.56,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001209191-22-034620","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584759/000120919122034620/doc4.xml","form_type":"4"}},{"id":2242516,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":40959,"kind":"person","name":"FLOWERS KIRSTEN","position":1,"cik":"0001797209","reported_name":"FLOWERS KIRSTEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-06T21:36:49.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 2, 2023 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":19500,"derivative":{"exercise_price":13.56,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001209191-22-034618","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1797209/000120919122034618/doc4.xml","form_type":"4"}},{"id":2241269,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":36227,"kind":"person","name":"BAUM CHARLES M","position":1,"cik":"0001579824","reported_name":"BAUM CHARLES M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-06T21:34:07.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 2, 2023 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders"}],"balance_after":19500,"derivative":{"exercise_price":13.56,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001209191-22-034607","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1579824/000120919122034607/doc4.xml","form_type":"4"}},{"id":2251886,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":24290,"kind":"person","name":"ORBIMED ADVISORS LLC","position":1,"cik":"0001055951","reported_name":"ORBIMED ADVISORS LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":53130,"kind":"organization","name":"OrbiMed Capital GP V LLC","position":2,"cik":"0001615374","reported_name":"OrbiMed Capital GP V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":24740,"kind":"person","name":"OrbiMed Genesis GP LLC","position":3,"cik":"0001808744","reported_name":"OrbiMed Genesis GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-05-31T20:36:35.000Z","date":"2022-05-26","kind":"sale","acquired":false,"shares":26253,"price":15.93,"value":418210.29,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the sale of shares of the Issuer's common stock (\"Shares\"), which was effected after market close on May 26, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These Shares were sold in multiple transactions at prices ranging from $15.55 to $16.09. The price reported reflects the weighted average sale price. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Shares are held of record by OrbiMed Genesis Master Fund, L.P. (\"Genesis Master Fund\"). OrbiMed Genesis GP LLC (\"Genesis GP\") is the general partner of Genesis Master Fund and OrbiMed Advisors LLC (\"OrbiMed Advisors\"), a registered investment advisor under the Investment Advisors Act of 1940, as amended, is the managing member of Genesis GP. By virtue of such relationships, Genesis GP and OrbiMed Advisors may be deemed to have voting and investment power with respect to the securities held by Genesis Master Fund. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by Genesis Master Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This report on Form 4 is jointly filed by OrbiMed Advisors, GP V and Genesis GP. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1943, as amended (the \"Exchange Act\"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any such entity is a beneficial owner of such securities for purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":87786,"source":{"system":"sec-edgar","filing":"0000947871-22-000675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055951/000094787122000675/ownership.xml","form_type":"4"}},{"id":2287707,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-29T21:15:13.000Z","date":"2022-04-27","kind":"exercise","acquired":false,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and immediately exercisable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Due to an administrative error, the Form 4 filed on May 24, 2021 overstated the number of derivative securities beneficially owned following the reported transaction by 6,207 shares and has been updated in this Form 4 to correct the error."}],"balance_after":393366,"derivative":{"exercise_price":0.53,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001209191-22-026341","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919122026341/doc4.xml","form_type":"4"}}],"next_cursor":"2022-04-29T21:15:13.000000Z,2287707"}